Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for Steroid Refractory Acute GI-GvHD
NCT07364617Phase 2Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Apr 2026
- Primary completion
- Feb 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in acute gastrointestinal graft-versus-host disease (aGI-GVHD), sponsored by Chang Gung Memorial Hospital. Started Apr 2026; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
acute gastrointestinal graft-versus-host disease (aGI-GVHD)
Beyond the preview
Go deeper on NCT07364617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07364617.